Astellas Pharma Inc. (ALPMY)

Astellas Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 22, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	17,115	19,482	25,437	28,985	28,585	28,860
Market Cap Growth	-17.19%	-23.41%	-12.24%	1.40%	-0.95%	0.37%
Enterprise Value	21,251	23,368	22,361	25,959	25,644	26,309
Last Close Price	9.52	10.75	14.20	15.58	15.44	15.24
PE Ratio	44.79	172.88	34.25	28.37	26.22	15.89
PS Ratio	1.67	1.84	2.23	2.72	2.53	2.39
PB Ratio	1.93	1.85	2.24	2.41	2.28	2.41
P/TBV Ratio	-	-	5.48	6.59	7.01	10.97
P/FCF Ratio	19.28	21.92	11.61	15.53	11.48	17.18
P/OCF Ratio	14.71	17.09	10.32	13.67	10.30	13.99
EV/Sales Ratio	1.86	2.20	1.96	2.43	2.27	2.18
EV/EBITDA Ratio	9.06	12.51	8.81	10.58	8.76	8.48
EV/EBIT Ratio	19.60	28.37	12.83	14.45	11.30	10.58
EV/FCF Ratio	19.87	26.29	10.20	13.90	10.30	15.66
Debt / Equity Ratio	0.61	0.63	0.14	0.15	0.20	0.32
Debt / EBITDA Ratio	2.56	3.57	0.61	0.72	0.86	1.25
Debt / FCF Ratio	6.11	7.50	0.70	0.94	1.01	2.30
Asset Turnover	0.51	0.53	0.63	0.56	0.54	0.62
Inventory Turnover	1.36	1.38	1.76	1.60	1.56	1.83
Quick Ratio	0.79	0.69	1.13	1.05	1.15	0.86
Current Ratio	1.10	0.93	1.45	1.34	1.47	1.09
Return on Equity (ROE)	3.45%	1.10%	6.65%	8.72%	9.02%	15.34%
Return on Assets (ROA)	3.03%	2.58%	6.05%	5.92%	6.83%	7.93%
Return on Capital (ROIC)	4.25%	3.61%	8.55%	8.17%	9.31%	11.27%
Earnings Yield	1.85%	0.58%	2.92%	3.53%	3.81%	6.29%
FCF Yield	5.19%	4.56%	8.62%	6.44%	8.71%	5.82%
Dividend Yield	6.52%	4.31%	3.18%	2.64%	2.46%	2.44%
Payout Ratio	229.26%	684.38%	101.66%	68.69%	63.15%	37.63%
Buyback Yield / Dilution	0.78%	1.39%	1.38%	0.41%	1.03%	2.91%
Total Shareholder Return	0.78%	5.70%	4.56%	3.05%	3.49%	5.35%

Source: S&P Capital IQ. Standard template. Financial Sources.